請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60610
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 劉?睿 | |
dc.contributor.author | Han-Ming Hsiao | en |
dc.contributor.author | 蕭漢明 | zh_TW |
dc.date.accessioned | 2021-06-16T10:23:19Z | - |
dc.date.available | 2018-08-17 | |
dc.date.copyright | 2013-08-17 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-15 | |
dc.identifier.citation | Agarwal, N., D. N. Kamra, L. C. Chaudhary, L. Agarwal, A. Sahoo, and N. N. Pathak. 2002. Microbial status and rumen enzyme profile of crossbred calves on different microbial feed additives. Lett. Appl. Microbiol. 34:329–336.
Anderson, R. C., A. L. Cookson, W. C. McNabb, W. J. Kelly, and N. C. Roy. 2010. Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol. Lett. 309:184–192. Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U.S.A. 101:17264–17269. Ank, N., M. B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, U. B. Jensen, F. Dagnaes-Hansen, A. R. Thomsen, Z. Chen, H. Haugen, K. Klucher, and S. R. Paludan. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J. Immunol. 180:2474–2485. Barrow, P. A. 1992. Probiotics for chickens. Page 255–257 in Probiotics: The Scientific Basis. R. Fuller, ed. Chapman and Hall, London. Baumgart, D. C., and A. U. Dignass. 2002. Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care 5: 685–694. Bermudez-Humaran, L. G., N. G. Cortes-Perez, Y. Le Loir, J. M. Alcocer-Gonzalez, R. S. Tamez-Guerra, R. M. de Oca-Luna, and P. Langella. 2004. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J. Med. Microbiol. 53: 427–433. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749–795. Bolotin, A., P. Wincker, S. Mauger, O. Jaillon, K. Malarme, J. Weissenbach, S. D. Ehrlich, and A. Sorokin. 2001. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 11: 731–753. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6:975–990. Borruel, N., F. Casellas, M. Antolin, M. Llopis, M. Carol, E. Espiin, J. Naval, F. Guarner, and J. R. Malagelada. 2003. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am. J. Gastroenterol. 98:865–870. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72:248–254. Brockmeier, U., M. Caspers, R. Freudl, A. Jockwer, T. Noll, and T. Eggert. 2006. Systematic screening of all signal peptides from Bacillus subtilis: a powerful strategy in optimizing heterologous protein secretion in Gram-positive bacteria. J. Mol. Biol. 362: 393–402. Brunner, M., and H. Bujard. 1987. Promoter recognition and promoter strength in the Escherichia coli system. EMBO J. 6:3139–3144. Chang, K., Z. Cai, C. Zhang, G. C. Sen, B. R. G. Williams, and G. Luo. 2006. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R dependent and PKR independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J. Virol. 80:7364–7374. Chou, L. S., and B. Weimer. 1999. Isolation and characterization of acid- and bile-tolerant isolates from strains of Lactobacillus acidophilus. J. Dairy Sci. 82:23–31. Corrier, D. E., A. Hinton, R. L. Ziprin, R. C. Beier, and J. R. DeLoach. 1990. Effect of dietary lactose on cecal pH, bacteriostatic volatile fatty acids, and Salmonella typhimurium colonization of broiler chicks. Avian Dis. 34:617–625. Cui, H. H., C. L. Chen, J. D. Wang, Y. J. Yang, Y. Cun, J. B. Wu, Y. H. Liu, H. L. Dan, Y. T. Jian, and X. Q. Chen. 2004. Effect of probiotic on intestinal mucosa of patients with ulcerative colitis. World J. Gastroenterol. 10:1521–1525. De Arauz, L. J., A. F. Jozala, P. G. Mazzola, and T. C. Vessoni Penna. 2009. Nisin biotechnological production and application: a review. Trends Food Sci. Technol. 20: 146–154. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon, or using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95:15623–15628. De Ruyter, P. G. G. A., O. P. Kuipers, and W. M. de Vos. 1996. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62:3662–3667. Dibner, J. J., and K. D. Richards. 2005. Antibiotic growth promoters in agriculture: history and mode of action. J. Poult. Sci. 84:634–643. Dunne, C., L. O’Mahony, L. Murphy, G. Thornton, D. Morrissey, S. O'Halloran, M. Feeney, S. Flynn, G. Fitzgerald, C. Daly, B. Kiely, G. C. O'Sullivan, F. Shanahan, and J. K. Collins. 2001. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. Clin. Nutr. 73: 386–392. Duval, M., C. J. Lewis, J. F. Nomellini, M. S. Horwitz, J. Smit, and L. A. Cavacini. 2011. Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus. Antimicrob. Agents Chemother. 55:5547–5552. EC, 2001. Commission of the European Communities, Commission Recommendation, 2001/459/EC. Official Journal of European Union L 161:42–44. Eid, P., J. F. Meritet, C. Maury, A. Lasfar, D. Weill, and M. G. Tovey. 1999. Oromucosal Interferon Therapy: Pharmacokinetics and Pharmacodynamics. J. Interferon Cytokine Res. 19:157–169. Fasano, A. 2000. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann. N. Y. Acad. Sci. 915:214–222. Fuller, R. 1989. Probiotics in man and animals. J.Appl. Bacteriol. 66:365–378. Fuglsang, A. 2003. Lactic acid bacteria as prime candidates for codon optimization. Biochem. Biophys. Res. Commun. 312: 285–291. Gaggia, F., P. Mattarelli, and B. Biavati. 2010. Probiotics and prebiotics in animal feeding for safe food production. Int. J. Food Microbiol. 141:15–28. Gill, H. S. 2003. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol 17:755–773. Gionchetti, P., F. Rizzello, U. Helwig, A. Venturi, K. M. Lammers, P. Brigidi, B. Vitali, G. Poggioli, M. Miglioli, and M. Campieri. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202–1209. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond, and M. Colonna. 2006. Essential role of MDA-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U.S.A. 103:8459–8464. Gossen, J. A., A. C. Molijn, G. R. Douglas, and J. Vijg. 1992. Application of galactose-sensitive E.coIi strains as selective hosts for LacZ- plasmids. Nucleic Acids Res. 20:3254. Hall, J. C., and Rosen, A. 2010. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat. Rev. Rheumatol. 6:40–49. Horisberger, M. A., and K. de Staritzky. 1985 . Sensitivity of influenza A viruses to human interferons in human diploid cells. FEMS Microbiol. Lett. 29:207–210. Horisberger, M. A., and K. de Staritzky. 1987. Recombinant human interferon-α b/d hybrid with a broad host-range. J. Gen. Virol. 68:945–948. Hooper, L. V., T. Midtvedt, and J. I. Gordon. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22:283–307. Hou, F., K. Liu, T. Shen, B. Zhou, R. Cao, P. Li, and P. Chen. 2010. Antiviral activity of rChIFN-α against vesicular stomatitis virus and Newcastle disease virus: A novel recombinant chicken interferon-α showed high antiviral activity. Res. Vet. Sci. 91:e73–79. Huang, P. Y., J. H. Guo, and L. H. Hwang. 2011. Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo. Mol. Ther. 20:298–305. Huppert, M., J. Cazin, and H. Smith. 1955. Pathogenesis of Candida albicans in the intestinal tract of mice. J. Bacteriol. 51:113–129. Hsueh, H. Y., P. Y. Yueh, B. Yu, X. Zhao, and J. R. Liu. 2010. Expression of Lactobacillus reuteri Pg4 collagen-binding protein gene in Lactobacillus casei ATCC 393 increases its adhesion ability to Caco-2 cells. Ilk, N., E. M. Egelseer, and U. B. Sleytr. 2011. S-layer fusion proteins ‐ construction principles and applications. Curr. Opin. Biotechnol. 22:824–31. Jensen, P. R., and K. Hammer. 1998. The sequence of spacers between the consensus sequences modulates the strength of prokaryotic promoters. Appl. Environ. Microbiol. 64: 82–87. Jiang, H., H. Yang, and D. R. Kapczynski. 2011. Chicken interferon alpha pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species. Virol. J. 8: 447. Jijon, H., J. Backer, H. Diaz, H. Yeung, D. Thiel, C. McKaigney, C. De Simone, and K. Madsen. 2004. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126: 1358–1373. Kalavathy, R., N. Abdullah, S. Jalaludin, and Y. W. Ho. 2003. Effects of Lactobacillus cultures on growth performance, abdominal fat deposition, serum lipids and weight of organs of broiler chickens. Br. Poult. Sci. 44:139–144. Kandler, O., and N. Weiss. 1986. Regular, nonsporing gram-positive rods. Page 1208–1234 in Bergey’s Manual of Systematic Bacteriology vol. 2. P. H. A. Sneath, ed. Williams and Wilkins, Baltimore, MD. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C. S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105. Kawai, T., and S. Akira. 2010. The role of pattern- recognition receptors in innate immunity: update on Toll- like recptors Nat. Immunol.11:373–384. Kim, E. B., C. Piao da, J. S. Son, and Y. J. Choi. 2009. Cloning and characterization of a novel tuf promoter from Lactococcus lactis subsp. lactis IL1403. Curr. Microbiol. 59: 425–431. Konstantinov, S. R., H. Smidt, A. D. L. Akkermans, L. Casini, P. Trevisi, M. Mazzoni, S. De Filippi, P. Bosi, and W. de Vos. 2008. Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels in the gut and promotes growth of infected piglets. FEMS Microbiol. Ecol. 66:599–607. Kristiansen, H., C. A. Scherer, M. McVean, S. P. Iadonato, S. Vends, K. Thavachelvam, T. B. Steffensen, K. A. Horan, T. Kuri, F. Weber, S. R. Paludan, and R. Hartmann. 2010. Extracellular 2’-5’ oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J. Virol. 84:11898–11904. Kuipers, O. P., M. M. Beerthuyzen, P. G. de Ruyter, E. J. Luesink, and W. M. de Vos. 1995. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J. Biol. Chem. 270: 27299–27304. Lencer, W. I. 2001. Microbes and microbial toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin. Am. J. Physiol. Gastrointest. Liver Physiol. 280:781–786. Levraud, J. P., P. Boudinot, I. Colin, A. Benmansour, N. Peyrieras, P. Herbomel, and G. Lutfalla. 2007. Identification of the zebrafish IFN receptor: implications for the origin of the vertebrate IFN system. J. Immunol. 178:4385–4394. Maertens, B., A. Spriestersbach, U. von Groll, U. Roth, J. Kubicek, M. Gerrits, M. Graf, M. Liss, D. Daubert, R. Wagner, and F. Schafer. 2010. Gene optimization mechanisms: a multigene study reveals a high success rate of full-length human proteins expressed in Escherichia coli. Protein Sci. 19:1312–1326. Mathur, S., and R. Singh. 2005. Antibiotic resistance in food lactic acid bacteria—a review. Int. J. Food Microbiol. 105:281–295. Mazmanian, S. K., J. L. Round, and D. Kasper. 2008. A microbial symbiosis factor prevents inflammatory disease. Nature 453:620–625. Meager, A. 2006. The interferons: characterization and application. Wiley- VCH Verlag GmbH and Company, KGaA, Weinheim. Meng, S., L. Yang, C. Xu, Z. Qin, H. Xu, Y. Wang, L. Sun, and W. Liu. 2010. Recombinant chicken interferon-α inhibits H9N2 avian influenza virus replication in vivo by oral administration. J. Interferon Cytokine Res. 31: 533–538. McCracken, V. J., and R. G. Lorenz. 2001. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell. Microbiol. 3:1–11. Modesto, M., M. R. D'Aimmo, I. Stefanini, P. Trevisi, S. De Filippi, L. Casini, M. Mazzoni, P. Bosi, and B. Biavati. 2009. A novel strategy to select Bifidobacterium strains and prebiotics as natural growth promoters in newly weaned pigs. Livest. Sci. 122:248–258. Moulin, H. R., M. Liniger, S. Python, L. G. Piriou, M. O. Macchi, N. Ruggli, and A. Summerfield. 2011. High interferon type I responses in the lung, plasma and spleen during highly pathogenic H5N1 infection of chicken. Vet. Res. 42: 6. Murch, S. H., C. P. Braegger, J. A. Walker-Smith, and T. T. MacDonald. 1993. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705–1709. Nemcova, R., A. Bomba, S. Gancarcikova, K. Reiffova, , P. Guba, J. Koscova, Z. Jonecova, L. Scirankova, and A. Bugarsky. 2007. Effects of the administration of lactobacilli, maltodextrins and fructooligosaccharides upon the adhesion of E. coli O8:K88 to the intestinal mucosa and organic acid levels in the gut contents of piglets. Vet. Res. Commun. 31:791–800. Nisbet, D. 2002. Defined competitive exclusion cultures in the prevention of enteropathogen colonisation in poultry and swine. Antonie van Leeuwenhoek 81:481–486. Qin, H., Z. Zhang, X. Hang, and Y. Jiang. 2009. L. plantarum prevents Enteroinvasive Escherichia coli induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 9:63. Rehberg, E., B. Kelder, E. G. Hoal, and S. Pestka. 1982. Specific molecular activity of recombinant and hybrid leukocyte interferons. J. Biol. Chem. 257:11497–11502. Rigoulay, C., I. Poquet, S. M. Madsen, and A. Gruss. 2004. Expression of the Staphylococcus aureus surface proteins HtrA1 and HtrA2 in Lactococcus lactis. FEMS Microbiol. Lett. 237:279–288. Rodriguez-Palacios, A., J. S. Weese, T. Duffield, and H. R. Staempfli. 2004. Effect of oral probiotics on calf diarrhoea: clinical trials published between 1973–2003. J. Vet. Intern. Med. 18:395–396. Rosenfeldt, V., E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen, N. H. Valerius, and A. Paerregaard. 2003. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111:389–395. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559–568. Salminen, S., E. Isolauri, and E. Salminen. 1996. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70:347–358. Salyers, A. A., A. Gupta, and Y. Wang. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412–416. Salzman, N. H., D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522–526. Sazawal, S., G. Hiremath, U. Dhingra, P. Malik, S. Deb, and R. E. Black. 2006. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6:374–382. Schneitz, C. 2005. Competitive exclusion in poultry—30 years of research. Food Control 16:657–667. Si, J. M., Y. C. Yu, Y. J. Fan, and S. J. Chen. 2004. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J. Gastroenterol. 10:1802–1805. Siggers, R. H., T. Thymann, J. L. Siggers, M. Schmidt, A. K. Hansen, and P. T. Sangilda. 2007. Bacterial colonization affects early organ and gastrointestinal growth in the neonate. Livest. Sci. 109:14–18. Sommereyns, C., S. Paul, P. Staeheli, and T. Michiels. 2008. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells response to interferons. Annu. Rev. Biochem. 67:227–264. Streuli, M., A. Hall, W. Boll, W. E. Stewart II, S. Nagata, and C. Weissman. 1981. Target cell specificity of two species of human interferons-α produced in Escherichia coli and of hybrid molecules derived from them. Proc. Natl. Acad. Sci. U.S.A. 78:2848–2852. Strompfova, V., A. Laukova, and A. C. Ouwehand. 2004. Selection of enterococci for potential canine probiotic additives. Vet. Microbiol. 100:107–114. Takahashi, S., Y. Egawa, N. Simojo, T. Tsukahara, and K. Ushid. 2007. Oral administration of Lactobacillus plantarum strain Lq80 to weaning piglets stimulates the growth of indigenous lactobacilli to modify the lactobacillal population. J. Gen. Appl. Microbiol. 53:325–332. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, Y. Ohba, and T. Taniguchi. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505. Thompson, J. L., and M. Hinton. 1997. Antibacterial activity of formic acid and propionic acid in the diet of hens on Salmonella in the crop. Br. Poult. Sci. 38:59–65. Tjalsma, H., H. Antelmann, J. D. Jongbloed, P. G. Braun, E. Darmon, R. Dorenbos, J. Y. Dubois, H. Westers, G. Zanen, W. J. Quax, O. P. Kuipers, S. Bron, M. Hecker, and J. M. van Dijl. 2004. Proteomics of protein secretion by Bacillus subtilis: separating the “secrets” of the secretome. Microbiol. Mol. Biol. Rev. 68: 207–233. Tien, M. T., S. E. Girardin, B. Regnault, L. Le Bourhis, M. A. Dillies, J. Y. Coppee, R. Bourdet-Sicard, P. J. Sansonetti, and T. Pedron. 2006. Anti-Inflammatory Effect of Lactobacillus casei on Shigella-Infected Human Intestinal Epithelial Cells. J. Immunol. 176:1228–1237. Timmerman, H. M., C. J. Koning, L. Mulder, F. M. Rombouts, and A. C. Beynen. 2004. Monostrain, multistrain and multispecies probiotics—a comparison of functionality and efficacy. Int. J. Food Microbiol. 96:219–233. Timmerman, H. M., L. Mulder, H. Everts, D. C. van Espen, E. van der Wal, G. Klaassen, S. M. Rouwers, R. Hartemink, F. M. Rombouts, and A. C. Beynen. 2005. Health and growth of veal calves fed milk replacers with or without probiotics. J. Dairy Sci. 88:2154–2165. Tschiggerl, H., A. Breitwieser, G. Roo, T. Verwoerd, C. Schaffer, and U. B. Sleytr. 2007. Exploitation of the S-layer self-assmbly system for site directed immobilization of enzymes demonstrated for an extremophilic laminarinase from Pyrococcus furiosus. J. Biotechnol. 133: 403–411. Tschiggerl, H., J. L. Casey, K. Parisi, M. Foley, and U. B. Sleytr. 2008. Display of a peptide mimotope on a crystalline bacterial cell surface layer (S-layer) lattice for diagnosis of Epstein-barr virus infection. Bioconjug. Chem. 19:860–865. Uno, K., Y. Suginoshita, K. Kakimi, Y. Moriyasu, K. Nakano, N. Nakamura, T. Fujita, Y. Horino, T. Sato, and T. Kishida. 2006. Clinical utility of 2’,5’-oligoadenylate synthetase activity measurement: using whole blood as a highly sensitive method to detect the effects of IFN. J. Virol. Methods 136:185–192. Van der Vossen, J. M., D. van der Lelie, and G. Venema. 1987. Isolation and characterization of Streptococcus cremoris Wg2-specifc promoters. Appl. Environ. Microbiol. 53: 2452–2457. Waterfi eld, N. R., R. W. Le Page, P. W. Wilson, and J. M. Wells. 1995. The isolation of lactococcal promoters and their use in investigating bacterial luciferase synthesis in Lactococcus lactis. Gene 165: 9–15. Weck, P. K., S. Apperson, L. May, and N. Stebbing. 1981a. Comparison of the antiviral activities of various cloned human interferon- | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60610 | - |
dc.description.abstract | 干擾素α為多數真核生物具有的細胞激素,具有抑制多種病毒增殖之能力,該激素在動物細胞受病毒感染後數小時內即產生,並誘導鄰近細胞之抗病毒基因表達,達到抑制病毒之能力。本試驗之目的是將益生菌Lactobacillus reuteri進行基因轉殖,使其帶有人干擾素α2b ( human interferon-α2b, huIFN )基因,之後測定mRNA及蛋白質層次之表現,並評估轉形株對細胞之抗病毒活性。
試驗將huIFN基因構築於乳酸菌-大腸桿菌穿梭載體pNZ3004。以電穿孔 (electroporation) 將重組質體轉殖至腸道益生菌L. reuteri Pg4中,透過載體上的Lactobacillus lactis lacA啟動子和訊號胜肽來調控huIFN表達並且外泌至菌體外。取得轉形菌落後以聚合酶鏈鎖反應(polymerase chain reaction, colony-PCR)確認其帶有huIFN基因並可轉錄huIFN之mRNA。進一步以專一性抗體進行酵素連結免疫吸附分析(enzyme – linked immunosorbent assay, ELISA),將培養16小時之L. reuteri Pg4及其轉形株以ELISA測定huIFN蛋白質表現量。試驗證實,於轉形株之胞內萃取物、細胞壁以及胞外培養液皆可測得huIFN蛋白質,其中以胞內萃取物中表現量為最高。為進一步了解轉形株表現huIFN蛋白質之穩定性,將L. reuteri Pg4及L. reuteri pNZ-huIFN轉形株進行24小時培養,測定生長曲線及huIFN蛋白質表現量,發現L. reuteri Pg4之菌數可於培養後8小時達9 log CFU/mL,然而L. reuteri pNZ-huIFN轉形株需要16小時才能達到將近9 log CFU/mL。在huIFN表現量中發現,於L. reuteri pNZ-huIFN轉形株之胞內萃取物、細胞壁以及胞外培養液中表現量具有相同模式,皆為先升高後下降,且亦以胞內萃取物之表現量最高。在抗病毒試驗中,將純化人干擾素α2b、L. reuteri Pg4及L. reuteri pNZ-huIFN轉形株之胞內萃取物對BHK細胞及293T細胞進行前處理,之後再以Sindbis virus ( SBV ) 進行感染,結果顯示無論在BHK細胞或者293T細胞中,純化人干擾素α2b、L. reuteri Pg4及L. reuteri pNZ-huIFN轉形株皆具有抗SBV活性。 綜觀上述,L. reuteri pNZ-huIFN轉形株可成功表達huIFN,在抗病毒試驗中也證實L. reuteri Pg4及L. reuteri pNZ-huIFN轉形株皆會降低SBV之感染效率,說明此乳酸菌株具有應用於畜禽飼料以做為病毒抑制劑之潛力。 | zh_TW |
dc.description.abstract | Interferon-α ( IFN-α ) is a cytokine that is able to inhibit various virus, and can be secreted from most eukaryotic cells. After viral infection, IFN-α can be expressed by the infected cells rapidly in few hours, and induces the expression of antiviral genes by cells to block the amplification of virus. The purpose of this study is to genetically modify a probiotic Lactobacillus reuteri strain to express the human IFN-α2b (huIFN), and to evaluate the antiviral activity of the L. reuteri transformants.
The DNA sequence of huIFN was amplified by PCR and subcloned into the Lactobacillus expression vector pNZ3004 that was able to secrete recombinant proteins into extracellular medium. After plasmid construction, the recombinant plasmid was used to transform L. reuteri Pg4 by electroporation. Once the L. reuteri transformants were obtained, direct colony PCR was performed to demonstrate the presence of huIFN gene, and reverse transcriptase-PCR analysis was performed to further confirm the transcription of RNA of huIFN. Moreover, the expression levels of the recombinant huIFN expressed by L. reuteri transformants were determined by ELISA during the bacterial growth period. The antiviral activities of the intracellular extract and extracellular medium of the L. reuteri transformants were evaluated in the BHK and 293T cell models of sindbis virus ( SBV ) infection. The results showed that huIFN was successfully expressed by the L. reuteri transformants. More amounts of huIFN were presented in the intracellular extract than in the cell wall pellet or extracellular medium of the L. reuteri transformants. The growth pattern of the L. reuteri transformants was similar to that of the wild type L. reuteri Pg4. The bacterial counts of the L. reuteri Pg4 in the initial fermentation were about 7 log CFU/mL, reached to 9 log CFU/mL after 8 hours of culturing, and remained the stationary phase till 24 hours. The expression levels of recombinant huIFN in the L. reuteri transformants increased with the incubation time, reached the highest levels at 8 hours, and then decreased. In the antiviral experiment, the intracellular extract of the L. reuteri transformants could decrease the replication of SBV in the BHK or 293T cells, similar to the pure huIFN protein. Interestingly, the intracellular extract and extracellular medium of the wild type L. reuteri also showed slight antiviral activity against SBV replication in the BHK or 293T cells. In conclusion, we successfully expressed huIFN by L. reuteri Pg4 and demonstrated the intracellular extract of the L. reuteri transformants did suppress the replication of SBV in cell culture. Therefore, we suggest that the L. reuteri transformants have potential to be used as an antiviral feed additive. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T10:23:19Z (GMT). No. of bitstreams: 1 ntu-102-R00626022-1.pdf: 2512431 bytes, checksum: 8637feef16a4cf6f068b37cc3d533c5a (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 中文摘要 1
英文摘要 2 第一章、文獻探討 4 一、益生菌 4 (一) 簡介 4 (二) 特性 4 二、乳酸桿菌 8 (一) 簡介 8 (二) 機能性 8 1. 增進腸道屏障效應 8 2. 調控宿主免疫系統 8 3. 家畜飼養之應用 9 三、乳酸菌表達外源性蛋白質 12 (一) 影響因子 12 (二) 分泌型外源性蛋白質表現系統 13 (三) 菌體表層蛋白質表現系統 14 四、干擾素 ( interferon, IFN ) 17 (一) 干擾素之種類及特性 17 (二) 干擾素於細胞中之誘導程序 17 (三) 第一型干擾素之抗病毒機制 19 (四) 第一型干擾素之抗病毒效應 20 第二章、材料方法 25 一、 人干擾素α2b基因之選殖與建構 25 二、 乳酸菌外泌型表現載體pNZ-huIFN之建構 30 三、 乳酸菌表現人干擾素α2b 30 (一) 乳酸菌勝任細胞之製備 30 (二) 電穿孔 ( electroporation ) 反應條件 31 (三) 測定L. reuteri Pg4及L.reuteri pNZ-huIFN轉形株之生長曲線 31 (四) L. reuteri pNZ-huIFN轉形株菌體蛋白質之定量 32 (五) 測定人干擾素α2b於L. reuteri pNZ-huIFN轉形株之mRNA轉錄量 35 (六) 酵素連結免疫吸附分析(enzyme-linked immunosorbent assay, ELISA) L. reuteri pNZ-huIFN轉形株表達人干擾素α2b 36 四、 BHK細胞及293T細胞培養 37 五、 Sindbis virus(SBV)之製備 39 六、測定經純化之人干擾素α2b、L. reuteri Pg4及L. reuteri pNZ-huIFN轉形株前處理的BHK細胞及293T細胞之抗SBV感染活性 42 第三章、結果與討論 45 一、以益生菌L. reuteri Pg4表達人干擾素α2b 45 (一) 人干擾素α2b表達質體之構築 45 (二) 確認L. reuteri pNZ-huIFN轉形株帶有人干擾素α2b基因及其mRNA之轉 錄量 45 (三) 酵素連結免疫吸附分析L. reuteri pNZ-huIFN轉形株之人干擾素α2b表達量 46 (四) 表達人干擾素α2b對L. reuteri pNZ-huIFN轉形株生長之影響 47 二、經純化之人干擾素α2b、L. reuteri Pg4及L. reuteri pNZ-huIFN轉形株前處理的BHK細胞及293T細胞之抗SBV感染活性 48 (一) BHK細胞之抗病毒試驗結果 49 (二) 293T細胞之抗病毒試驗結果 50 (三) 純化之人干擾素α2b、L. reuteri Pg4及L. reuteri pNZ-huIFN293T前處理293T細胞影響其干擾素α2b下游基因ISG 56 ( human interferon stimulated gene 56 )表現量 50 第四章、結論 65 參考文獻 66 | |
dc.language.iso | zh-TW | |
dc.title | 應用乳酸桿菌表達人干擾素α2b及評估其抗病毒效應 | zh_TW |
dc.title | Expression of Human Interferon-α2b by Probiotic Lactobacillus reuteri Pg4 and Evaluation of its Antiviral Activity | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 余碧,鄭光成,劉啟德,陳明汝 | |
dc.subject.keyword | 干擾素α,病毒,Lactobacillus reuteri, | zh_TW |
dc.subject.keyword | Interferon-α,Sindbis virus,Lactobacillus reuteri, | en |
dc.relation.page | 78 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-08-16 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 2.45 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。